Pharma companies moved fast in 2020 to tackle Covid-19 and to address longstanding issues of racial equity, the CEOS of BD and Sanofi said in a session at the J.P. Morgan Healthcare Conference. The challenge lies in keeping the momentum going in 2021.
Qiagen Launches Portable Digital SARS-CoV-2 Antigen Test in the US Published: Nov 13,2020 | Tags: Antigen Test, Digital, Launches, Portable, Qiagen, SARS-CoV-2, US GSK and Medicago Initiate P-II/III Study of its Plant-Derived COVID-19 Vaccine Published: Nov 13,2020 | Tags: COVID-19, GSK, Initiate, Medicago, P-II/III, Plant-… Read More »PharmaShots Weekly Snapshots (Nov 09-13, 2020)
Shots: The acquisition expands the BD’s medication management offerings into the care continuum space and provides deeper integration with EHRs The Medical Business of CUBEX’s key offering is a cloud-based software supporting decentralized medication management and provides unique features specialized for pharmacists and nurses across… Read More »BD Acquires the Medical Business Assets of CUBEX
Earlier this month, Ohio Gov. Mike DeWine received a false-positive result from a rapid antigen test for Covid-19, raising concerns about the tests’ accuracy. The assay’s maker, Quidel, said it is investigating the case.